MedTrace Logo

Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study

NCT06493786 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-07-10

No results posted yet for this study

Summary

The aim of this research is to determine which volatile organic compounds (odors) are associated with different skin cancers.

To this end, odor samples will be taken from various parts of the body, from patients with skin cancers and from "healthy" subjects who have no skin cancer.

The various samples collected will be analyzed in the laboratory, and compared with each other, to determine whether there is a specific "smell" for the main types of skin cancer.

Conditions

  • Identify Volatile Biomarkers Specific to Malignant Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma
  • Verify That the Volatile Biomarkers Identified Derive From Metabolic Changes in Body Odour and Not Just From Changes in the Surface of Cancerous Lesions

Interventions

OTHER

Collection of body odor samples

Skin odor is collected using polymer sticks, placed in contact with the skin for approximately 1 hour. In this study, odor collection will be carried out on the thigh, forearm, armpit, neck and, if applicable, on the cancerous lesion.

Sponsors & Collaborators

  • SenseBioTek Health-Care

    collaborator UNKNOWN

  • ESPCI Paris

    collaborator OTHER

  • Association pour la Recherche Clinique et Immunologique

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2025-07-31
Completion
2025-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06493786 on ClinicalTrials.gov